Zaleplon and Latuda drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zaleplon (zaleplon) and Latuda (lurasidone hydrochloride). Common drug interactions include age-related macular degeneration among females and sleep apnoea syndrome among males.

The phase IV clinical study analyzes what interactions people have when they take Zaleplon and Latuda. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Zaleplon?

Zaleplon has active ingredients of zaleplon. It is often used in insomnia. eHealthMe is studying from 1,935 Zaleplon users. Check the latest studies of Zaleplon.

What is Latuda?

Latuda has active ingredients of lurasidone hydrochloride. It is often used in bipolar disorder. eHealthMe is studying from 21,543 Latuda users. Check the latest studies of Latuda.

On Jul, 05, 2026

18 people who take Zaleplon and Latuda together, and have interactions are studied.

What are the common drug interactions of Zaleplon and Latuda, by gender? *:

female:

Age-related macular degeneration
Drug ineffective
Dysphonia (speech disorder attributable to a disorder of phonation)
Hypertension (high blood pressure)
Muscle spasms (muscle contraction)
Pneumonia
Seasonal allergy (allergic condition due to certain season)
Surgery
Dyskinesia (abnormality or impairment of voluntary movement)
Macular degeneration (painless eye condition that leads to the gradual loss of central vision)

male:

Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Suicidal ideation
Suicide attempt
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Haematemesis (vomiting of blood)
Lethargy (tiredness)
Nausea (feeling of having an urge to vomit)
Somnolence (a state of near-sleep, a strong desire for sleep)
Therapeutic response unexpected
Tinnitus (a ringing in the ears)

What are the common drug interactions of Zaleplon and Latuda, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Haematemesis (vomiting of blood)
Nausea (feeling of having an urge to vomit)
Therapeutic response unexpected
Tinnitus (a ringing in the ears)
Gastrointestinal disorder (functional problems of gastrointestinal tract)

30-39:

Gastric bypass
Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
Malaise (a feeling of general discomfort or uneasiness)
Uterine leiomyoma (uterine benign tumour derived from smooth muscle)

40-49:

Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Suicidal ideation
Suicide attempt

50-59:

Dyskinesia (abnormality or impairment of voluntary movement)
Tremor (trembling or shaking movements in one or more parts of your body)

60+:

n/a

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 33.33%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 22.22%
Sleep Disorder: 4 people, 22.22%
Depression: 4 people, 22.22%
Post-Traumatic Stress Disorder: 3 people, 16.67%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 3 people, 16.67%
Cystitis Interstitial (unknown cause characterized by bladder pain): 3 people, 16.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 16.67%
Asthma: 3 people, 16.67%
Stress And Anxiety: 3 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Zaleplon and Latuda?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously